Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Magnitude of Platelet Inhibition Inversely Correlate With the Number of TCD-detected Microemboli in Asymptomatic Patients Undergoing Carotid Artery Stenting Prior to Cardiac Surgery Who Are Being Pre-treated With 300 mg or 600 mg Loading Dose of Clopidogrel?

NCT01146301 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.

NCT NCT01146301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01146301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Magnitude of Platelet Inhibition Inversely Correlate With the Number of TCD-detected Microemboli in Asymptomatic Patients Undergoing Carotid Artery Stenting Prior to Cardiac Surgery Who Are Being Pre-treated With 300 mg or 600 mg Loading Dose of Clopidogrel?
Lead sponsor
R&D Cardiologie
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
April 30, 2010
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid stenosis